lenalidomide

Generic: lenalidomide

Labeler: padagis us llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name lenalidomide
Generic Name lenalidomide
Labeler padagis us llc
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

lenalidomide 20 mg/1

Manufacturer
Padagis US LLC

Identifiers & Regulatory

Product NDC 0574-1420
Product ID 0574-1420_dffe719b-4f61-47e2-b71c-673322d487f5
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA217265
Listing Expiration 2026-12-31
Marketing Start 2026-01-31

Pharmacologic Class

Established (EPC)
thalidomide analog [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 05741420
Hyphenated Format 0574-1420

Supplemental Identifiers

RxCUI
602910 602912 643712 643720 1242231 1428947
UNII
F0P408N6V4
NUI
N0000184014

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name lenalidomide (source: ndc)
Generic Name lenalidomide (source: ndc)
Application Number ANDA217265 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 20 mg/1
source: ndc
Packaging
  • 21 CAPSULE in 1 BOTTLE (0574-1420-21)
source: ndc

Packages (1)

Ingredients (1)

lenalidomide (20 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "dffe719b-4f61-47e2-b71c-673322d487f5", "openfda": {"nui": ["N0000184014"], "unii": ["F0P408N6V4"], "rxcui": ["602910", "602912", "643712", "643720", "1242231", "1428947"], "spl_set_id": ["dffe719b-4f61-47e2-b71c-673322d487f5"], "pharm_class_epc": ["Thalidomide Analog [EPC]"], "manufacturer_name": ["Padagis US LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "21 CAPSULE in 1 BOTTLE (0574-1420-21)", "package_ndc": "0574-1420-21", "marketing_start_date": "20260131"}], "brand_name": "LENALIDOMIDE", "product_id": "0574-1420_dffe719b-4f61-47e2-b71c-673322d487f5", "dosage_form": "CAPSULE", "pharm_class": ["Thalidomide Analog [EPC]"], "product_ndc": "0574-1420", "generic_name": "lenalidomide", "labeler_name": "Padagis US LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "LENALIDOMIDE", "active_ingredients": [{"name": "LENALIDOMIDE", "strength": "20 mg/1"}], "application_number": "ANDA217265", "marketing_category": "ANDA", "marketing_start_date": "20260131", "listing_expiration_date": "20261231"}